Do Hedge Funds and Insiders Love Colgate-Palmolive Company (CL)?

Page 1 of 2

Colgate-Palmolive Company (NYSE:CL) has experienced a decrease in hedge fund interest of late.

In the eyes of most stock holders, hedge funds are viewed as worthless, old investment tools of the past. While there are over 8000 funds with their doors open at the moment, we at Insider Monkey look at the crème de la crème of this club, close to 450 funds. It is estimated that this group controls most of the hedge fund industry’s total capital, and by tracking their top equity investments, we have revealed a few investment strategies that have historically outstripped the broader indices. Our small-cap hedge fund strategy outperformed the S&P 500 index by 18 percentage points a year for a decade in our back tests, and since we’ve began to sharing our picks with our subscribers at the end of August 2012, we have outclassed the S&P 500 index by 23.3 percentage points in 8 months (explore the details and some picks here).

Colgate-Palmolive Company (NYSE:CL)Just as key, positive insider trading activity is a second way to parse down the marketplace. As the old adage goes: there are plenty of reasons for an executive to downsize shares of his or her company, but just one, very obvious reason why they would initiate a purchase. Several academic studies have demonstrated the market-beating potential of this strategy if investors understand where to look (learn more here).

Consequently, let’s take a gander at the key action surrounding Colgate-Palmolive Company (NYSE:CL).

What does the smart money think about Colgate-Palmolive Company (NYSE:CL)?

In preparation for this quarter, a total of 29 of the hedge funds we track were long in this stock, a change of -6% from the first quarter. With the smart money’s positions undergoing their usual ebb and flow, there exists a select group of noteworthy hedge fund managers who were upping their stakes considerably.

According to our comprehensive database, Jim Simons’s Renaissance Technologies had the largest position in Colgate-Palmolive Company (NYSE:CL), worth close to $490.9 million, accounting for 1.2% of its total 13F portfolio. Sitting at the No. 2 spot is Lansdowne Partners, managed by Paul Ruddock and Steve Heinz, which held a $462.2 million position; the fund has 6.3% of its 13F portfolio invested in the stock. Some other hedgies that hold long positions include Jean-Marie Eveillard’s First Eagle Investment Management, William von Mueffling’s Cantillon Capital Management and Bill Miller’s Legg Mason Capital Management.

Judging by the fact that Colgate-Palmolive Company (NYSE:CL) has witnessed bearish sentiment from the entirety of the hedge funds we track, it’s safe to say that there exists a select few hedgies that decided to sell off their entire stakes last quarter. Intriguingly, David Blood and Al Gore’s Generation Investment Management dumped the largest stake of the 450+ funds we track, comprising an estimated $78.6 million in stock., and Ray Dalio of Bridgewater Associates was right behind this move, as the fund dropped about $11.1 million worth. These transactions are important to note, as total hedge fund interest fell by 2 funds last quarter.

What do corporate executives and insiders think about Colgate-Palmolive Company (NYSE:CL)?

Insider trading activity, especially when it’s bullish, is best served when the company in question has experienced transactions within the past six months. Over the latest half-year time period, Colgate-Palmolive Company (NYSE:CL) has experienced zero unique insiders buying, and 24 insider sales (see the details of insider trades here).

Let’s go over hedge fund and insider activity in other stocks similar to Colgate-Palmolive Company (NYSE:CL). These stocks are Energizer Holdings, Inc. (NYSE:ENR), Avon Products, Inc. (NYSE:AVP), The Procter & Gamble Company (NYSE:PG), Estee Lauder Companies Inc (NYSE:EL), and Kimberly Clark Corp (NYSE:KMB). This group of stocks are the members of the personal products industry and their market caps resemble CL’s market cap.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!